BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lencioni R, Crocetti L, Della Pina MC, Cioni D. Guidelines for imaging focal lesions in liver cirrhosis. Expert Review of Gastroenterology & Hepatology 2014;2:697-703. [DOI: 10.1586/17474124.2.5.697] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Lencioni R. Surveillance and early diagnosis of hepatocellular carcinoma. Digestive and Liver Disease 2010;42:S223-7. [DOI: 10.1016/s1590-8658(10)60509-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
2 Buell JF, Tranchart H, Cannon R, Dagher I. Management of Benign Hepatic Tumors. Surgical Clinics of North America 2010;90:719-35. [DOI: 10.1016/j.suc.2010.04.006] [Cited by in Crossref: 45] [Cited by in F6Publishing: 35] [Article Influence: 3.8] [Reference Citation Analysis]
3 Albiin N. MRI of Focal Liver Lesions. Curr Med Imaging Rev. 2012;8:107-116. [PMID: 23049491 DOI: 10.2174/157340512800672216] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 4.5] [Reference Citation Analysis]
4 Dai QS, Gu HL, Ye S, Zhang YJ, Lin XJ, Lau WY, Peng ZW, Chen MS. Transarterial chemoembolization vs. conservative treatment for unresectable infiltrating hepatocellular carcinoma: A retrospective comparative study. Mol Clin Oncol. 2014;2:1047-1054. [PMID: 25279196 DOI: 10.3892/mco.2014.391] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
5 Yu H, Bai Y, Xie X, Feng Y, Yang Y, Zhu Q. RECIST 1.1 versus mRECIST for assessment of tumour response to molecular targeted therapies and disease outcomes in patients with hepatocellular carcinoma: a systematic review and meta-analysis. BMJ Open 2022;12:e052294. [DOI: 10.1136/bmjopen-2021-052294] [Reference Citation Analysis]
6 Lin MT, Wang CC, Cheng YF, Eng HL, Yen YH, Tsai MC, Tseng PL, Chang KC, Wu CK, Hu TH. Comprehensive Comparison of Multiple-Detector Computed Tomography and Dynamic Magnetic Resonance Imaging in the Diagnosis of Hepatocellular Carcinoma with Varying Degrees of Fibrosis. PLoS One 2016;11:e0166157. [PMID: 27829060 DOI: 10.1371/journal.pone.0166157] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
7 Del Poggio P, Olmi S, Ciccarese F, Di Marco M, Rapaccini GL, Benvegnù L, Borzio F, Farinati F, Zoli M, Giannini EG, Caturelli E, Chiaramonte M, Trevisani F; Italian Liver Cancer (ITA.LI.CA) Group. Factors that affect efficacy of ultrasound surveillance for early stage hepatocellular carcinoma in patients with cirrhosis. Clin Gastroenterol Hepatol 2014;12:1927-33.e2. [PMID: 24582947 DOI: 10.1016/j.cgh.2014.02.025] [Cited by in Crossref: 64] [Cited by in F6Publishing: 69] [Article Influence: 8.0] [Reference Citation Analysis]
8 Mehta N, Fidelman N, Sarkar M, Yao FY. Factors associated with outcomes and response to therapy in patients with infiltrative hepatocellular carcinoma. Clin Gastroenterol Hepatol. 2013;11:572-578. [PMID: 23333661 DOI: 10.1016/j.cgh.2012.12.030] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
9 Llovet JM, Lencioni R. mRECIST for HCC: Performance and novel refinements. J Hepatol. 2020;72:288-306. [PMID: 31954493 DOI: 10.1016/j.jhep.2019.09.026] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 48.0] [Reference Citation Analysis]
10 Rosenberg C, Jahn A, Pickartz T, Wahnschaffe U, Patrzyk M, Hosten N. Gd-EOB-DTPA-enhanced MR guidance in thermal ablation of liver malignancies. PLoS One 2014;9:e109217. [PMID: 25541950 DOI: 10.1371/journal.pone.0109217] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
11 Sherman M. The radiological diagnosis of hepatocellular carcinoma. Am J Gastroenterol. 2010;105:610-612. [PMID: 20203642 DOI: 10.1038/ajg.2009.663] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 3.1] [Reference Citation Analysis]
12 Ayuso C, Rimola J, Forner A. [Imaging techniques in hepatocellular carcinoma: diagnosis, extension and evaluation of therapeutic response]. Gastroenterol Hepatol 2010;33:721-6. [PMID: 20447736 DOI: 10.1016/j.gastrohep.2010.01.012] [Reference Citation Analysis]
13 Esser M, Schneeweiss S, Nikolaou K, Horger M. Complexity of Ultrasound and CT Fusion Examinations: Are They Feasible in the Daily Routine? American Journal of Roentgenology 2016;207:712-7. [DOI: 10.2214/ajr.16.16246] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
14 Mancebo A, Varela M, González-diéguez ML, Navascués CA, Cadahía V, Mesa-álvarez A, Rodrigo L, Rodríguez M. Incidence and risk factors associated with hepatocellular carcinoma surveillance failure: Hepatocellular carcinoma surveillance. Journal of Gastroenterology and Hepatology 2018;33:1524-9. [DOI: 10.1111/jgh.14108] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
15 Maillard E. [Epidemiology, natural history and pathogenesis of hepatocellular carcinoma]. Cancer Radiother 2011;15:3-6. [PMID: 21239205 DOI: 10.1016/j.canrad.2010.11.010] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]